Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 139th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
NMRA	NEUMORA THERAPEUTICS INC	$314.98M	-181.70%	-119.20%	-175.90%	-430.60%	1.18	5.10	N/A	N/A	N/A
SANA	SANA BIOTECHNOLOGY INC	$1.13B	-134.50%	-51.10%	-68.82%	-165.80%	1.79	1.38	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$2.77B	-7.70%	-6.00%	-6.54%	-6.90%	0.30	14.57	100.00%	-54.70%	-54.75%
RKTO	ROCKET ONE INC	$15.21M	-165.20%	-143.60%	-280.82%	-3,991.50%	0.34	3.39	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$168.40M	-108.00%	-85.80%	-138.37%	-301.80%	0.35	4.52	100.00%	-7,724.00%	-7,723.97%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$414.12M	-53.50%	-51.20%	-32.22%	-215.30%	0.07	19.30	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$323.48M	-41.30%	-39.00%	-30.40%	-108.00%	0.03	30.14	N/A	N/A	N/A
JUNS	JUPITER NEUROSCIENCES INC	$2.27M	N/A	-228.60%	323.14%	2,487.40%	-2.42	0.51	78.80%	-22,690.80%	-22,237.32%
ANRO	ALTO NEUROSCIENCE INC	$1.01B	-47.20%	-38.80%	-27.32%	-305.80%	0.14	20.52	N/A	N/A	N/A
RXRX	RECURSION PHARMACEUTICALS INC	$1.81B	-50.40%	-38.30%	-47.90%	-300.40%	0.33	5.03	3.50%	-945.90%	-954.27%
MGX	METAGENOMI THERAPEUTICS INC	$45.71M	-63.60%	-44.50%	-64.11%	-50.70%	0.54	4.50	100.00%	-689.20%	-690.60%
MPLT	MAPLIGHT THERAPEUTICS INC	$543.24M	N/A	N/A	N/A	N/A	0.05	22.91	N/A	N/A	N/A
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$264.46M	-151.00%	-54.70%	-53.96%	-53.20%	4.47	8.26	99.50%	-186.30%	-172.51%
TARA	PROTARA THERAPEUTICS INC	$219.76M	-38.70%	-36.00%	-34.59%	-44.50%	0.06	15.69	N/A	N/A	N/A
TNGX	TANGO THERAPEUTICS INC	$3.81B	-41.50%	-33.40%	-25.45%	-44.90%	0.11	27.38	100.00%	-188.20%	-188.20%
VRCA	VERRICA PHARMACEUTICALS INC	$89.67M	-444.40%	-76.60%	-202.22%	-301.60%	7.36	1.45	85.90%	-102.80%	-90.53%
KROS	KEROS THERAPEUTICS INC	$210.96M	-21.40%	-19.80%	-31.26%	-227.00%	0.10	21.96	100.00%	-553.90%	-573.44%
MLYS	MINERALYS THERAPEUTICS INC	$2.25B	-27.90%	-27.00%	-23.78%	-38.70%	0.02	44.33	N/A	N/A	N/A
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$1.41B	-83.20%	-58.50%	-48.07%	-195.50%	0.34	12.56	N/A	N/A	N/A
EDSA	EDESA BIOTECH INC	$49.08M	-82.30%	-75.40%	-102.41%	1,789.60%	0.22	4.76	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$288.37M	-33.20%	-27.80%	-33.72%	-351.60%	0.19	12.08	100.00%	-311.10%	-307.96%
EYPT	EYEPOINT INC	$1.13B	-135.80%	-108.30%	-164.55%	-174.50%	0.37	4.50	41.80%	-10,994.70%	-10,988.67%
VKTX	VIKING THERAPEUTICS INC	$3.94B	-94.60%	-82.70%	-129.73%	-121.50%	0.28	4.72	N/A	N/A	N/A
ENGN	ENGENE THERAPEUTICS INC	$121.92M	-56.10%	-45.60%	-43.39%	-50.00%	0.21	12.57	N/A	N/A	N/A
AARD	AARDVARK THERAPEUTICS INC	$156.86M	-61.70%	-56.30%	-80.32%	-99.60%	0.13	8.06	N/A	N/A	N/A
MSLE	SATELLOS BIOSCIENCE INC	$208.73M	N/A	N/A	N/A	N/A	0.07	16.48	N/A	N/A	N/A
MIST	MILESTONE PHARMACEUTICALS INC	$158.11M	-339.40%	-61.80%	-35.49%	-52.90%	4.37	9.18	99.20%	-3,832.00%	-3,437.50%
CGON	CG ONCOLOGY INC	$6.83B	-25.20%	-24.00%	-21.61%	-26.00%	0.06	22.22	-85.20%	-3,602.70%	-3,602.68%
DYN	DYNE THERAPEUTICS INC	$4.99B	-64.30%	-50.30%	-55.08%	-119.40%	0.42	12.02	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$0.00	-123.30%	-63.00%	-141.42%	225.20%	1.36	0.27	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$97.87M	N/A	-322.30%	-1,208.00%	1,534.50%	-2.59	1.38	N/A	N/A	N/A
CRIS	CURIS INC	$4.50M	N/A	-79.50%	-143.86%	284.50%	1.34	1.11	99.60%	-299.70%	-299.66%
TENX	TENAX THERAPEUTICS INC	$60.63M	-61.50%	-57.40%	-57.10%	2,144.10%	0.07	15.07	N/A	N/A	N/A
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$736.99M	-61.50%	-41.00%	-41.16%	-122.10%	0.12	6.16	N/A	N/A	N/A
ZNTL	ZENTALIS PHARMACEUTICALS INC	$294.57M	-70.20%	-51.50%	-78.13%	-59.30%	0.50	4.82	N/A	N/A	N/A
IVVD	INVIVYD INC	$202.69M	-53.50%	-41.60%	-36.94%	-396.90%	0.19	6.47	92.90%	-138.90%	-138.90%
UPB	UPSTREAM BIO INC	$385.84M	-43.80%	-42.30%	-51.50%	-55.90%	0.05	23.14	100.00%	-4,719.00%	-4,718.96%
PRQR	PROQR THERAPEUTICS NV	$206.80M	-86.20%	-38.40%	-68.68%	-3,620.80%	1.63	2.48	100.00%	-333.50%	-322.16%
SION	SIONNA THERAPEUTICS INC	$230.58M	-32.90%	-31.10%	-35.74%	-38.70%	0.07	20.05	N/A	N/A	N/A
HELP	CYBIN INC	$520.96M	-74.30%	-63.40%	-63.85%	-487.90%	0.08	9.52	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$163.36M	-46.80%	-43.30%	-43.97%	-52.80%	0.11	10.40	92.90%	-519.30%	-516.91%
ELDN	ELEDON PHARMACEUTICALS INC	$289.45M	-150.30%	-53.90%	-59.65%	-64.20%	1.03	8.44	N/A	N/A	N/A
OSTX	OS THERAPIES INC	$71.26M	N/A	-422.40%	364.62%	417.70%	-1.58	0.05	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$1.68B	-57.80%	-47.30%	-51.43%	-57.40%	0.18	6.65	100.00%	-672.20%	-672.16%
CING	CINGULATE INC	$69.04M	-365.20%	-158.50%	-139.27%	-960.40%	0.64	2.55	N/A	N/A	N/A
ELTX	ELICIO THERAPEUTICS INC	$57.83M	-2,748.20%	-151.10%	-251.11%	-271.50%	-16.79	2.24	N/A	N/A	N/A
VNDA	VANDA PHARMACEUTICALS INC	$298.08M	-85.00%	-56.80%	-71.32%	-102.30%	0.87	1.61	93.70%	-127.40%	-82.14%
CMPX	COMPASS THERAPEUTICS INC	$396.19M	-38.70%	-34.70%	-42.20%	-44.30%	0.15	11.22	N/A	N/A	N/A
NKTX	NKARTA INC	$166.70M	-30.90%	-24.20%	-28.24%	-23.70%	0.30	12.96	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$911.03M	-45.90%	-41.20%	-38.30%	-51.00%	0.10	10.88	N/A	N/A	N/A
VRDN	VIRIDIAN THERAPEUTICS INC	$2.60B	-61.30%	-46.00%	-35.93%	-50.50%	0.66	16.95	100.00%	-544.10%	-522.11%
TRAW	TRAWS PHARMA INC	$8.20M	-859.20%	-126.00%	291.96%	220.20%	-2.54	0.43	100.00%	-539.70%	-539.70%
TCRX	TSCAN THERAPEUTICS INC	$50.78M	-91.90%	-50.10%	-66.76%	-76.90%	1.08	6.65	100.00%	-1,360.60%	-1,330.19%
TVRD	TVARDI THERAPEUTICS INC	$16.60M	-64.20%	-43.90%	-106.04%	-456.50%	0.78	2.25	N/A	N/A	N/A
TYRA	TYRA BIOSCIENCES INC	$1.50B	-46.40%	-43.10%	-41.41%	-58.10%	0.08	14.91	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$2.18B	-84.10%	-66.80%	-81.37%	-81.00%	0.31	10.92	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$183.94M	-87.10%	-74.20%	-96.59%	-108.90%	0.24	5.71	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$227.59M	-59.30%	-48.60%	-38.12%	-105.00%	0.17	8.42	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$486.74M	N/A	-27.40%	-37.63%	-45.10%	-0.03	8.36	100.00%	-10,288.40%	-10,411.37%
CRDF	CARDIFF ONCOLOGY INC	$71.79M	-95.50%	-71.50%	-128.96%	-123.40%	0.42	3.27	100.00%	-8,530.90%	-8,526.10%
WVE	WAVE LIFE SCIENCES LTD	$994.11M	-50.40%	-40.10%	-39.90%	-642.30%	0.23	9.99	100.00%	-309.70%	-309.73%
ANVS	ANNOVIS BIO INC	$65.48M	-318.10%	-215.50%	-1,185.14%	1,243.50%	4.20	1.27	N/A	N/A	N/A
SEER	SEER INC	$118.76M	-26.60%	-23.50%	-26.87%	-26.50%	0.13	17.73	48.70%	-464.80%	-464.06%
IMRN	IMMURON LTD	$8.98M	-39.70%	-34.00%	-34.91%	-154.80%	0.16	8.04	69.50%	-52.30%	-52.16%
IBO	IMPACT BIOMEDICAL INC	$46.36M	13.70%	4.50%	-10.40%	160.40%	0.25	0.16	-1,111.40%	2,254.30%	-4,368.57%
JAGX	JAGUAR HEALTH INC	$472.25k	N/A	-115.60%	1,023.95%	-172.70%	-3.75	0.50	85.10%	-169.50%	-112.61%
GTBP	GT BIOPHARMA INC	$11.29M	-1,215.40%	-790.90%	-627.23%	7,096.10%	0.32	4.14	N/A	N/A	N/A
GRI	GRI BIO INC	$3.90M	-199.50%	-143.20%	-103.44%	705.10%	0.08	14.21	N/A	N/A	N/A
PCSA	PROCESSA PHARMACEUTICALS INC	$7.23M	-281.30%	-200.80%	-555.19%	14,525.90%	0.78	0.98	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$7.55M	-40.60%	-35.00%	-40.76%	683.50%	0.15	7.44	100.00%	-75.90%	-75.91%
GNPX	GENPREX INC	$2.15M	-247.30%	-176.70%	-98.66%	6,750.40%	0.20	5.61	N/A	N/A	N/A
PULM	PULMATRIX INC	$5.84M	-102.10%	-91.60%	-126.04%	1,823.20%	0.25	4.96	N/A	N/A	N/A
LONA	LEONABIO INC	$71.58M	-381.00%	-225.70%	-199.33%	-1,888.60%	0.45	10.38	N/A	N/A	N/A
LPCN	LIPOCINE INC	$17.23M	-64.70%	-57.60%	-54.44%	-87.60%	0.10	11.48	100.00%	-755.10%	-755.11%
SER	SERINA THERAPEUTICS INC	$41.69M	-407.70%	-155.10%	-99.43%	-13,025.00%	0.55	4.18	100.00%	-16,583.10%	-16,030.77%
IPHA	INNATE PHARMA SA	$201.50M	N/A	-56.60%	-176.67%	-145.70%	-3.89	1.28	100.00%	-546.10%	-511.46%
HRTX	HERON THERAPEUTICS INC	$61.51M	-300.90%	-13.60%	-16.48%	-9.70%	35.52	2.49	70.10%	-22.50%	-17.46%
NEUP	NEUPHORIA THERAPEUTICS INC	$20.59M	-76.90%	-54.80%	-53.47%	815.70%	0.18	14.31	100.00%	131,387.10%	134,189.48%
KYNB	KYNTRA BIO INC	$28.62M	-208.50%	120.20%	211.56%	172.20%	-2.72	3.61	40.70%	2,199.40%	2,318.26%
KAPA	KAIROS PHARMA LTD	$7.77M	-92.30%	-86.40%	-109.90%	-284.40%	0.08	10.31	N/A	N/A	N/A
OBX	OBSIDIAN THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-0.06	4.21	N/A	N/A	N/A
NCNA	NUCANA PLC	$0.00	-153.70%	-116.10%	-83.75%	1,556.30%	0.23	5.48	N/A	N/A	N/A
OGEN	ORAGENICS INC	$2.48M	-177.30%	-121.30%	-151.99%	-1,916.60%	0.21	5.73	N/A	N/A	N/A
IGC	IGC PHARMA INC	$28.13M	-94.50%	-71.60%	-103.74%	-294.10%	0.50	0.40	29.70%	-552.10%	-552.11%
TECH	BIO-TECHNE CORP	$11.30B	5.50%	4.30%	6.49%	12.30%	0.22	4.49	65.00%	9.00%	12.86%
IMA	IMAGENEBIO INC	$63.68M	-39.60%	-35.40%	-38.15%	-106.10%	0.07	21.47	N/A	N/A	N/A
INAB	IN8BIO INC	$10.35M	-91.20%	-76.90%	-95.77%	-366.50%	0.18	8.21	N/A	N/A	N/A
YDES	YD BIO LTD	$193.25M	N/A	-67.70%	-68.50%	464.80%	-5.83	5.88	28.10%	-1,392.60%	-1,392.86%
TIL	INSTIL BIO INC	$50.80M	-39.80%	-22.40%	-21.00%	-14.50%	0.81	39.87	N/A	N/A	N/A
INTS	INTENSITY THERAPEUTICS INC	$11.35M	-136.80%	-105.80%	-106.41%	-9,023.60%	0.23	4.86	N/A	N/A	N/A
GOSS	GOSSAMER BIO INC	$42.71M	N/A	-96.10%	-234.12%	-56.10%	-1.80	2.20	100.00%	-324.80%	-305.18%
KPRX	KIORA PHARMACEUTICALS INC	$11.59M	-63.40%	-44.30%	-57.27%	-111.20%	0.41	8.97	N/A	N/A	N/A
YARW	YARROW BIOSCIENCE INC	$28.64M	-69.60%	-62.70%	-87.08%	-257.30%	0.05	20.87	100.00%	-4,726.20%	-4,725.33%
SDEV	STABLECOIN DEVELOPMENT CORP	$52.64M	-205.20%	-156.60%	-98.41%	-178.80%	0.00	29.98	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$15.94M	-57.40%	-53.60%	-35.97%	2,534.30%	0.03	35.40	N/A	N/A	N/A
SNTI	SENTI BIOSCIENCES HOLDINGS INC	$11.12M	-503.80%	-97.90%	-215.02%	-104.90%	13.91	1.04	100.00%	-135,650.00%	-135,650.00%
LIMN	LIMINATUS PHARMA INC	$5.03M	N/A	-671.50%	10,974.32%	234.70%	-22.04	0.96	N/A	N/A	N/A
FBLG	FIBROBIOLOGICS INC	$6.86M	-536.80%	-225.10%	-313.58%	-389.40%	0.71	2.64	N/A	N/A	N/A
TOVX	THERIVA BIOLOGICS INC	$10.56M	-190.80%	-64.20%	-76.68%	-133.80%	1.48	1.63	100.00%	-7,656.30%	-7,153.00%
FBRX	FORTE BIOSCIENCES INC	$1.57B	-106.20%	-85.50%	-170.84%	641.40%	0.60	2.75	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Aug 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 45, which is 21 points higher than the biotech industry average of 24.

PBYI passed 14 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 80.82% over the past year, overperforming other biotech stocks by 88 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -31.58% from Puma Biotechnology's current stock price of $8.77.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: C, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -5 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates ICCC as a "A".

ICCC passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 64.41% over the past year, overperforming other biotech stocks by 71 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the #3 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Corcept Therapeutics (NASDAQ:CORT) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Corcept Therapeutics (NASDAQ:CORT) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

CORT passed 17 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 55.43% over the past year, overperforming other biotech stocks by 62 percentage points.

Corcept Therapeutics has an average 1 year price target of $122.60, an upside of 9.6% from Corcept Therapeutics's current stock price of $111.86.

Corcept Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Corcept Therapeutics, 60% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 20% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 31.05%, which is 26 percentage points higher than the biotech industry average of 5.37%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.88%, which is 1 percentage points higher than the biotech industry average of 5.37%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.7%, which is -3 percentage points lower than the biotech industry average of 5.37%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.12% in the last day, and up 3.4% over the last week. Pds Biotechnology was the among the top losers in the biotechnology industry, dropping -64.84% yesterday.

PDS Biotechnology shares are trading lower after the company issued CEO letter outlining plans to advance PDS0301 and pursue partnerships for PDS0101 after ceasing internal investment in its Phase 3 study.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 14, which is 1 points higher than the biotech industry average of 13. It passed 1 out of 7 valuation due diligence checks.

Exelixis's stock has gained 37.21% in the past year. It has overperformed other stocks in the biotech industry by 44 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 30 points higher than the biotech industry average of 13. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 13.56% in the past year. It has overperformed other stocks in the biotech industry by 20 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 57, which is 44 points higher than the biotech industry average of 13. It passed 4 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 123.91% in the past year. It has overperformed other stocks in the biotech industry by 131 percentage points.

Are biotech stocks a good buy now?

68.09% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 48.53% over the next year.

3.46% of biotech stocks have a Zen Rating of A (Strong Buy), 4.11% of biotech stocks are rated B (Buy), 41.77% are rated C (Hold), 38.96% are rated D (Sell), and 11.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Immucell (NASDAQ:ICCC)

3. Corcept Therapeutics (NASDAQ:CORT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Exelixis (NASDAQ:EXEL)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Immucell (NASDAQ:ICCC)

3. Corcept Therapeutics (NASDAQ:CORT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Exelixis (NASDAQ:EXEL)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.